In resolved epidermal keratinocytes, significant overexpression of AKR1B10 may decrease the level of RA by suppressing the RA synthesis pathway and increase cell survival and proliferation by activating the retinal–retinol pathway. The gene discussed is AKR1B10; the disease is rheumatoid arthritis.